|
Meridian Bioscience, Inc. - Comparative Business Analysis Snapshot
Business Description
Meridian Bioscience, Inc.. The Group's principal activity is to develop, manufacture and market disposable diagnostic test kits for rapid diagnosis of infectious diseases. It operates through three segments: US Diagnostics, European Diagnostics and Life Science. The US Diagnostics segment focuses on the development, manufacture and distribution of diagnostic test kits, primarily for certain respiratory, gastrointestinal, viral and parasitic infectious diseases. The European Diagnostics segment focuses on the sale and distribution of diagnostic test kits, manufactured by the US Diagnostics operating segment and others manufactured by third-party vendors. The Life Science segment focuses on the development, manufacture, sale and distribution of bulk antigens and reagents used by researchers and other diagnostic companies.
Competitor Analysis
This analysis compares Meridian Bioscience, Inc. with three other companies in closely related industry sectors.
The full Comparative Business Report is available to Subscribers or may be purchased individually. The full report generally includes the following sections:
- Sales Analysis: Recent Sales, Sales Growth, Sales per Employee
- Recent Stock Performance
- Company Valuation Ratios: Price/Earnings, Price/Book Value
- Price/Sales and 52 Week Price change
- Dividend Analysis
- Profitability Analysis: Gross Profit Margin, EBITDA Margin
- Earnings Before Extraordinary Items
- Inventory Analysis
- Research and Development Expenses
- Financial Position: Long Term Debt/Equity, Days Accounts Receivable, Days Inventory
- R&D Expenses/Sales
Not the Report you are looking for? Click here for more browsing options.
|
